Olema Pharmaceuticals, Inc. - Common Stock (NQ:OLMA)

Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference

November 21, 2025

Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

November 20, 2025

On Thursday, there are stocks with unusual volume. Let's take a look.

In today's session, these stocks are experiencing unusual volume. ↗

November 20, 2025

Via Chartmill

Keep an eye on the top gainers and losers in Thursday's session. ↗

November 20, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 20, 2025

Via Benzinga

Investment Powerhouse Backs Biotech Stock to the Tune of $419 Million ↗

November 20, 2025

Bain Capital added more than 12.4 million shares of HeartFlow stock in the thrid quarter

Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday ↗

Topics Artificial Intelligence Regulatory Compliance

November 20, 2025

Via Benzinga

Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer ↗

November 20, 2025

Bain Capital's bet on Cidara Therapeutics stocks has paid off in a big way

Let's explore the current happenings on the US markets on Wednesday. Below, you'll find the stocks exhibiting unusual volume in today's session.

Topics Regulatory Compliance

In today's session, these stocks are experiencing unusual volume. ↗

November 19, 2025

Via Chartmill

Biotech Stock Gets Booted in Latest Fund Update ↗

November 19, 2025

Bain Capital sold its entire stake in Nuvalent stock during the third quarter.

Bain Capital completely exited its position in Disc Medicine stock during the third quarter

Topics Regulatory Compliance

Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock ↗

November 19, 2025

Olema Oncology Announces Pricing of $190.0 Million Public Offering of Common Stock

November 19, 2025

Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

November 18, 2025

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

Which stocks are moving on Tuesday? ↗

November 18, 2025

Via Chartmill

Which stocks are most active on Tuesday? ↗

November 18, 2025

Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume!

Via Chartmill

Why Bain Capital Is Selling Shares of This Biotech Stock Now ↗

November 18, 2025

Bain Capital sold $20 million worth of Pharvaris stock during the third quarter.

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Topics Regulatory Compliance

Top movers in Tuesday's session ↗

November 18, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 18, 2025

Via Benzinga

Pharma Bro Martin Shkreli Shorts Olema Pharmaceuticals Stock ↗

November 18, 2025

"Pharma Bro' and notorious bear Martin Shkreli is shorting Olema Pharmaceuticals stock.

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

November 18, 2025

Today's session on Tuesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results ↗

November 18, 2025

Roche was evaluating Giredestrant as an adjuvant endocrine treatment for people with certain types of early-stage breast cancer.

Via Stocktwits

Amer Sports Posts Upbeat Q3 Earnings, Joins Diginex, James Hardie Industries And Other Big Stocks Moving Higher On Tuesday ↗

November 18, 2025

Via Benzinga

Cancer Focused Olema Pharmaceuticals Stock Soars 150% - Here's Why ↗

November 18, 2025

Roche posts positive phase 3 results for giredestrant in early breast cancer, showing improved disease-free survival and a favorable safety profile.

Via Benzinga

Dow Falls Over 300 Points; Home Depot Posts Downbeat Earnings ↗

November 18, 2025

Via Benzinga

Topics Stocks

Why Roche's Positive Test Results Sent Olema Pharma Skyrocketing 200% ↗

November 18, 2025

The companies are both working on oral selective estrogen receptor degraders, which break down the estrogen cancer cells need to grow.

Via Investor's Business Daily

Topics Government

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 18, 2025

Via Benzinga

Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

November 18, 2025

Via Benzinga

Olema Oncology Reports Third Quarter 2025 Financial and Operating Results

November 10, 2025

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 04, 2025